Table 1 Characteristics of the study population
Characteristics | Cases N (%) | Controls N (%) | OR [IC] | (P value) |
|---|---|---|---|---|
Sample size | 101 | 101 | Â | Â |
Age (mean years ± SD) | 70.66 ± 8.32 | 68.96 ± 9.19 |  |  |
Smoking status | ||||
Non-smoker | 37(36.63) | 45(44.45) | Â | Â |
Smoker | 64(63.37) | 56(55.44) | 1.39 [0.8, 2.4] | 0.25 |
Clinical criteria | ||||
Total PSA Rate (ng/ml) | ||||
PSA ≤ 10 | 8 (08.00) |  |  |  |
10 < PSA < 50 | 29 (38.67) |  |  |  |
PSA ≥ 50 | 64 (53.33) |  |  |  |
mean (± SD) | 74.49 ± 33.77 |  |  |  |
The Gleason score | ||||
GS ≤ 7 | 37(36.63) |  |  |  |
GS > 7 | 64(63.36) |  |  |  |
Clinical stage | ||||
Localized | 42(41.58) | Â | Â | Â |
Advanced | 59(58.41) | Â | Â | Â |